Biogenix HCV Rapid Card - 50 Test (BIR-023)

The Biogenix HCV Rapid Card (BIR-023) is an advanced diagnostic solution engineered for the swift and accurate detection of Hepatitis C Virus (HCV) infections. This immunochromatographic assay is designed for the qualitative detection of Hepatitis C Virus (HCV) antibodies, including IgG, IgM, and IgA, in human samples. It specifically targets antibodies generated against recombinant HCV antigens from the core, NS3, NS4, and NS5 regions of the HCV genome, providing a robust tool for timely diagnosis and intervention in clinical settings.

This rapid card is compatible with various human sample types, including whole blood, serum, or plasma. It delivers rapid results, with clear interpretations available within 10 to 20 minutes, facilitating efficient diagnostic workflows. For optimal accuracy, results should be read within 15 minutes and not after 20 minutes.

For storage, unused test devices should be kept unopened at temperatures between 2-30°C. It is crucial not to freeze the kit components. The Biogenix HCV Rapid Card is compliant with IVD Directive 98/79/EC, CE-marked, and ISO certified, ensuring adherence to stringent quality assurance standards for in vitro diagnostic use.

Key Features : 

Qualitative detection of Hepatitis C Virus (HCV) antibodies (IgG, IgM, IgA)
Compatible with human whole blood, serum, or plasma samples
Store at 2-30°C
Compliant with IVD Directive 98/79/EC, CE-marked, and ISO certified